2019
DOI: 10.1002/cam4.2083
|View full text |Cite
|
Sign up to set email alerts
|

Smoking can increase nasopharyngeal carcinoma risk by repeatedly reactivating Epstein‐Barr Virus: An analysis of a prospective study in southern China

Abstract: Background The association between smoking and nasopharyngeal carcinoma ( NPC ) is still uncertain. The aim of this study was to validate smoking effect on NPC and explore if smoking can induce NPC by persistently reactivating EBV in long‐term based on a prospective cohort design. Methods A NPC screening cohort with 10 181 eligible resid… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
21
0
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(25 citation statements)
references
References 57 publications
2
21
0
1
Order By: Relevance
“…Further research on a larger sample size (at least 1,129 subjects, with 80% power) is warranted. Indeed, a recent prospective cohort study on 10,181 residents in Sihui city (27), southern China, showed that in non-NPC subjects, ever smokers were associated with higher odds of EBV seropositivity at baseline (VCA-IgA: adjusted OR = 1.40, 95% CI = 1.22–1.60; EBNA1-IgA: 1.58, 1.38–1.82), and in the 3–5 years of follow up (VCA-IgA: 1.68, 1.29–2.18; EBNA1-IgA: 1.92, 1.42–2.59).…”
Section: Discussionmentioning
confidence: 99%
“…Further research on a larger sample size (at least 1,129 subjects, with 80% power) is warranted. Indeed, a recent prospective cohort study on 10,181 residents in Sihui city (27), southern China, showed that in non-NPC subjects, ever smokers were associated with higher odds of EBV seropositivity at baseline (VCA-IgA: adjusted OR = 1.40, 95% CI = 1.22–1.60; EBNA1-IgA: 1.58, 1.38–1.82), and in the 3–5 years of follow up (VCA-IgA: 1.68, 1.29–2.18; EBNA1-IgA: 1.92, 1.42–2.59).…”
Section: Discussionmentioning
confidence: 99%
“…Evidence from large perspective epidemiological studies has suggested that elevated antibodies could be detected 5‐10 years preceding NPC diagnosis and NPC risk could increase by 20‐30 times in people with elevated levels of EBV antibodies . Several serological EBV antibodies, such as VCA‐IgA, EA‐IgA, and ENBA1‐IgA have served as the effective biomarkers in the screening of NPC in endemic areas for decades . Moreover, serological profiles of EBV have been evidenced in clinical practice to be indicative of tumor burden, treatment response and prognosis of NPC patients .…”
Section: Introductionmentioning
confidence: 99%
“…The virus may be reactivated during periods of environmental stress, whereby the EBV antibodies against viral antigens become elevated. Smokers have higher levels of anti-EBV antibodies 26,27 and higher EBV viral load 28,29 compared to nonsmokers, and several studies indicate that smoking may trigger EBV reactivation 30,31 .…”
Section: Discussionmentioning
confidence: 99%